{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:33:13Z","timestamp":1791275593106,"version":"4.1.0"},"reference-count":53,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,7,5]],"date-time":"2004-07-05T00:00:00Z","timestamp":1088985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Fetal haemoglobin (HbF, <jats:italic>\u03b1<\/jats:italic>2) decreases polymerization of sickle haemoglobin (HbS) and high levels correlate with decreased morbidity and mortality in sickle cell disease (SSD). Therefore, a therapeutic goal in SSD is the pharmacologic reactivation of HbF. Silencing of the globin (HbF) gene is associated with DNA methylation. The cytosine analogues 5\u2010azacytidine and 5\u2010aza\u20102\u2032\u2010deoxycytidine (decitabine) hypomethylate DNA by inhibiting DNA methyl\u2010transferase. In clinical trials, 5\u2010azacytidine and decitabine have demonstrated the greatest efficacy in HbF reactivation. Clinical development of these drugs has been delayed by concerns regarding the carcinogenic potential of 5\u2010azacytidine. Furthermore, controversy regarding DNA hypomethylation <jats:italic>versus<\/jats:italic> more generic cytotoxic effects as the mechanism of action suggested that other cytotoxic\/cytostatic agents might be as effective. Additional preclinical data and clinical studies of decitabine have tempered many safety concerns and have confirmed that DNA hypomethylation is the mechanism of action. Pharmacologic reactivation of HbF through DNA hypomethylation holds promise as an effective disease modifying intervention for patients with SSD. Larger studies are required to confirm safety and effectiveness with chronic use.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05064.x","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T16:13:43Z","timestamp":1093364023000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["DNA hypo\u2010methylating agents and sickle cell disease"],"prefix":"10.1111","volume":"126","author":[{"given":"Yogen","family":"Saunthararajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,5]]},"reference":[{"key":"e_1_2_19_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1780"},{"key":"e_1_2_19_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200103000-00010"},{"key":"e_1_2_19_4_1","first-page":"7089","article-title":"Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer","volume":"63","author":"Belinsky S.A.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_19_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371107"},{"key":"e_1_2_19_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/5.12.1583"},{"key":"e_1_2_19_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.89"},{"key":"e_1_2_19_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00072-8"},{"key":"e_1_2_19_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.15.4842"},{"key":"e_1_2_19_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001"},{"key":"e_1_2_19_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V21.3.261.261"},{"key":"e_1_2_19_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.14.4428"},{"key":"e_1_2_19_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3905"},{"key":"e_1_2_19_14_1","first-page":"447","article-title":"Pharmacologic manipulation of fetal hemoglobin synthesis","volume":"191","author":"Dover G.J.","year":"1985","journal-title":"Progress in Clinical and Biological Research"},{"key":"e_1_2_19_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083557"},{"key":"e_1_2_19_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1067703"},{"key":"e_1_2_19_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083558"},{"key":"e_1_2_19_18_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.2.2.349"},{"key":"e_1_2_19_19_1","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/S0021-9258(17)40407-8","article-title":"Participation of hemoglobins A and F in polymerization of sickle hemoglobin","volume":"252","author":"Goldberg M.A.","year":"1977","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_19_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.9.4681"},{"key":"e_1_2_19_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.11797"},{"key":"e_1_2_19_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.65.1.18"},{"key":"e_1_2_19_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.7.2379"},{"key":"e_1_2_19_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90329-1"},{"key":"e_1_2_19_25_1","first-page":"817","article-title":"Mutagenicity of 5\u2010azacytidine and related nucleosides in C3H\/10T 1\/2 clone 8 and V79 cells","volume":"42","author":"Landolph J.R.","year":"1982","journal-title":"Cancer Research"},{"key":"e_1_2_19_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.2.343"},{"key":"e_1_2_19_27_1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V67.4.1083.1083","article-title":"On the mechanism of Hb F elevations in the baboon by erythropoietic stress and pharmacologic manipulation","volume":"67","author":"Lavelle D.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_19_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6616(03)00207-9"},{"key":"e_1_2_19_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212093072401"},{"key":"e_1_2_19_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V62.2.370.370"},{"key":"e_1_2_19_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291205"},{"key":"e_1_2_19_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2001.02933.x"},{"key":"e_1_2_19_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197710)40:4 <1930::AID-CNCR2820400826>3.0.CO;2-8"},{"key":"e_1_2_19_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.22.6907"},{"key":"e_1_2_19_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/10.11.2003"},{"key":"e_1_2_19_36_1","first-page":"4757","article-title":"Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5\u2010azacytidine","volume":"62","author":"McGregor F.","year":"2002","journal-title":"Cancer Research"},{"key":"e_1_2_19_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2431"},{"key":"e_1_2_19_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.2.670"},{"key":"e_1_2_19_39_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-1-1"},{"key":"e_1_2_19_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_19_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(80)90086-0"},{"key":"e_1_2_19_42_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.5.925"},{"key":"e_1_2_19_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1738"},{"key":"e_1_2_19_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10427"},{"key":"e_1_2_19_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.1078"},{"key":"e_1_2_19_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1645"},{"key":"e_1_2_19_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(88)90011-3"},{"key":"e_1_2_19_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/13.6.1039"},{"key":"e_1_2_19_49_1","first-page":"245","article-title":"The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation","volume":"5","author":"Van Lint C.","year":"1996","journal-title":"Gene Expression"},{"key":"e_1_2_19_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.5.1493.1493"},{"key":"e_1_2_19_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-194804000-00008"},{"key":"e_1_2_19_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90073-V"},{"key":"e_1_2_19_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<252::AID-AJH10>3.0.CO;2-B"},{"key":"e_1_2_19_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1089523"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05064.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05064.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05064.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:53:57Z","timestamp":1697392437000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05064.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05064.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05064.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,5]]},"assertion":[{"value":"2004-07-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}